Delivery of biopharmaceuticals using combination of liposome and iontophoresis: a review

Ali MFM, Salah M, Rafea M, Saleh N (2008) Liposomal methotrexate hydrogel for treatment of localized psoriasis: preparation, characterization and laser targeting. Med Sci Monit 14:66–74 Alvarez-Figueroa M, Blanco-Mendez J (2001) Transdermal delivery of methotrexate: iontophoretic delivery from hydrogels and passive delivery from microemulsions. Int J Pharm 215:57–65 Badkar A, Betageri G, Hofmann G, Banga A (1999) Enhancement of transdermal iontophoretic delivery of a liposomal formulation of colchicine by electroporation. Drug Deliv 6:111–115 Baek J-S, Lim J-H, So J-W, Kim J-I, Lee T-W, Hwang S-J, Shin S-C, Kim S-J, Cho C-W (2012) The feasibility study of transdermal drug delivery systems for antidepressants possessing hydrophilicity or hydrophobicity. J Pharm Investig 42:109–114 Bagniefski T, Burnette RR (1990) A comparison of pulsed and continuous current iontophoresis. J Controlled Release 11:113–122 Balasubramaniam A, Anil Kumar V, Sadasivan Pillai K (2002) Formulation and in vivo evaluation of niosome-encapsulated daunorubicin hydrochloride. Drug Dev Ind Pharm 28:1181–1193 Banga AK (2002) Electrically assisted transdermal and topical drug delivery. CRC Press, Boca Raton Banga AK, Chien YW (1993) Hydrogel-based lontotherapeutic delivery devices for transdermal delivery of peptide/protein drugs. Pharm Res 10:697–702 Banga AK, Katakam M, Mitra R (1995) Transdermal iontophoretic delivery and degradation of vasopressin across human cadaver skin. Int J Pharm 116:211–216 Barry BW (2001) Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci 14:101–114 Benson HA, Namjoshi S (2008) Proteins and peptides: strategies for delivery to and across the skin. J Pharm Sci 97:3591–3610 Bhalaria M, Naik S, Misra A (2009) Ethosomes: a novel delivery system for antifungal drugs in the treatment of topical fungal diseases. Indian J Exp Biol 47:368 Bhatia A, Kumar R, Katare OP (2004) Tamoxifen in topical liposomes: development, characterization and in vitro evaluation. J Pharm Pharm Sci 7:252–259 Bhatia A, Singh B, Bhushan S, Katare OP (2010) Tamoxifen-encapsulated vesicular systems: cytotoxicity evaluation in human epidermal keratinocyte cell line. Drug Dev Ind Pharm 36:350–354 Boinpally RR, Zhou S-L, Devraj G, Anne PK, Poondru S, Jasti BR (2004) Iontophoresis of lecithin vesicles of cyclosporin A. Int J Pharm 274:185–190 Bommannan DB, Tamada J, Leung L, Potts RO (1994) Effect of electroporation on transdermal lontophoretic delivery of luteinizing hormone releasing hormone (LHRH) in vitro. Pharm Res 11:1809–1814 Bouwstra JA, Cheng K, Gooris G, Weerheim A, Ponec M (1996) The role of ceramides 1 and 2 in the stratum corneum lipid organisation. Biochim Biophys Acta 1300:177–186 Brown GL, Curtsinger LJ, White M, Mitchell RO, Pietsch J, Nordquist R, von Fraunhofer A, Schultz GS (1988) Acceleration of tensile strength of incisions treated with EGF and TGF-beta. Ann Surg 208:788 Burnette RR, Marrero D (1986) Comparison between the lontophoretic and passive transport of thyrotropin releasing hormone across excised nude mouse skin. J Pharm Sci 75:738–743 Burnette RR, Ongpipattanakul B (1987) Characterization of the permselective properties of excised human skin during iontophoresis. J Pharm Sci 76:765–773 Cevc G, Blume G (2001) New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, Transfersomes. Biochim Biophys Acta (BBA) 1514:191–205 Cevc G, Blume G (2004) Hydrocortisone and dexamethasone in very deformable drug carriers have increased biological potency, prolonged effect, and reduced therapeutic dosage. Biochim Biophys Acta 1663:61–73 Cevc G, Gebauer D, Stieber J, Schätzlein A, Blume G (1998) Ultraflexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. Biochim Biophys Acta 1368:201–215 Cevc G, Vierl U, Mazgareanu S (2008) Functional characterisation of novel analgesic product based on self-regulating drug carriers. Int J Pharm 360:18–28 Chang S-L, Hofmann GA, Zhang L, Deftos LJ, Banga AK (2000) Transdermal iontophoretic delivery of salmon calcitonin. Int J Pharm 200:107–113 Chang C-C, Yang W-T, Ko S-Y, Hsu Y-C (2012) Liposomal curcuminoids for transdermal delivery: iontophoresis potential for breast cancer chemotherapeutics. Dig J Nanomater Biostruct 7(1):59–71 Chen H, Zhu H, Zheng J, Mou D, Wan J, Zhang J, Shi T, Zhao Y, Xu H, Yang X (2009) Iontophoresis-driven penetration of nanovesicles through microneedle-induced skin microchannels for enhancing transdermal delivery of insulin. J Controlled Release 139:63–72 Chien YW (1991) Transdermal route of peptide and protein drug delivery. Dekker, New York, pp 667–689 Chien YW, Siddiqui O, Shi WM, Lelawongs P, Liu JC (1989) Direct current iontophoretic transdermal delivery of peptide and protein drugs. J Pharm Sci 78:376–383 Chung S-J (1999) Future drug delivery research in South Korea. J Controlled Release 62:73–79 Clemessy M, Couarraze G, Bevan B, Puisieux F (1995) Mechanisms involved in lontophoretic transport of angiotensin. Pharm Res 12:998–1002 Conjeevaram R, Chaturvedula A, Betageri GV, Sunkara G, Banga AK (2003) Iontophoretic in vivo transdermal delivery of β-blockers in hairless rats and reduced skin irritation by liposomal formulation. Pharm Res 20:1496–1501 Costello CT, Jeske AH (1995) Iontophoresis: applications in transdermal medication delivery. Phys Ther 75:554–563 Craane-van Hinsberg W, Bax L, Flinterman N, Verhoef J, Junginger H, Bodde H (1994) Iontophoresis of a model peptide across human skin in vitro: effects of iontophoresis protocol, pH, and ionic strength on peptide flux and skin impedance. Pharm Res 11:1296–1300 Cullander C, Rao G, Guy R (1993) Why silver/silver chloride? Criteria for iontophoresis electrodes. Predict Percutaneous Penetr 3:381–390 Dayan N, Touitou E (2000) Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. Biomaterials 21:1879–1885 De Leeuw J, De Vijlder H, Bjerring P, Neumann H (2009) Liposomes in dermatology today. J Eur Acad Dermatol Venereol 23:505–516 Degim Z, Ünal N, Eşsiz D, Abbasoglu U (2004) The effect of various liposome formulations on insulin penetration across Caco-2 cell monolayer. Life Sci 75:2819–2827 Del Terzo S, Behl CR, Nash RA (1989) Iontophoretic transport of a homologous series of ionized and nonionized model compounds: influence of hydrophobicity and mechanistic interpretation. Pharm Res 6:85–90 Delgado-Charro MB, Guy RH (1995) Iontophoretic delivery of nafarelin across the skin. Int J Pharm 117:165–172 Dubey V, Mishra D, Dutta T, Nahar M, Saraf D, Jain N (2007) Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. J Controlled Release 123:148–154 Dubey V, Mishra D, Nahar M, Jain V, Jain NK (2010) Enhanced transdermal delivery of an anti-HIV agent via ethanolic liposomes. Nanomedicine 6:590–596 Egbaria K, Weiner N (1990) Liposomes as a topical drug delivery system. Adv Drug Deliv Rev 5:287–300 El Maghraby GM, Campbell M, Finnin BC (2005) Mechanisms of action of novel skin penetration enhancers: phospholipid versus skin lipid liposomes. Int J Pharm 305:90–104 El Maghraby GM, Williams AC, Barry BW (2006) Can drug-bearing liposomes penetrate intact skin? J Pharm Pharmacol 58:415–429 El Maghraby GM, Barry BW, Williams AC (2008) Liposomes and skin: from drug delivery to model membranes. Eur J Pharm Sci 34:203–222 El Zaafarany GM, Awad GA, Holayel SM, Mortada ND (2010) Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery. Int J Pharm 397:164–172 Elias P (1987) Plastic wrap revisited: the stratum corneum two-compartment model and its clinical implications. Arch Dermatol 123:1405–1406 Elias PM (1988) Structure and function of the stratum corneum permeability barrier. Drug Dev Res 13:97–105 Elzainy AA, Gu X, Simons FER, Simons KJ (2003) Hydroxyzine from topical phospholipid liposomal formulations: evaluation of peripheral antihistaminic activity and systemic absorption in a rabbit model. AAPS J 5:41–48 Elzainy AA, Gu X, Simons FER, Simons KJ (2004) Cetirizine from topical phosphatidylcholine-hydrogenated liposomes: evaluation of peripheral antihistaminic activity and systemic absorption in a rabbit model. AAPS J 6:7–12 Erdogan M, Wright J, McAlister V (2002) Liposomal tacrolimus lotion as a novel topical agent for treatment of immune-mediated skin disorders: experimental studies in a murine model. Br J Dermatol 146:964–967 Essa EA, Bonner MC, Barry BW (2002) Iontophoretic estradiol skin delivery and tritium exchange in ultradeformable liposomes. Int J Pharm 240:55–66 Essa EA, Bonner MC, Barry BW (2004) Electrically assisted skin delivery of liposomal estradiol; phospholipid as damage retardant. J Controlled Release 95:535–546 Fang J-Y, Sung K, Lin H-H, Fang C-L (1999) Transdermal iontophoretic delivery of enoxacin from various liposome-encapsulated formulations. J Controlled Release 60:1–10 Fang J-Y, Hong C-T, Chiu W-T, Wang Y-Y (2001a) Effect of liposomes and niosomes on skin permeation of enoxacin. Int J Pharm 219:61–72 Fang J-Y, Yu S-Y, Wu P-C, Huang Y-B, Tsai Y-H (2001b) In vitro skin permeation of estradiol from various proniosome formulations. Int J Pharm 215:91–99 Foldvari M (1994) In vitro cutaneous and percutaneous delivery and in vivo efficacy of tetracaine from liposomal and conventional vehicles. Pharm Res 11:1593–1598 Foldvari M, Gesztes A, Mezei M (1990) Dermal drug delivery by liposome encapsulation: clinical and electron microscopic studies. J Microencapsul 7:479–489 Garnock-Jones KP (2013) Sumatriptan iontophoretic transdermal system: a review of its use in patients with acute migraine. Drugs 73:1483–1490 Ghanbarzadeh S, Arami S (2013) Enhanced transdermal delivery of diclofenac sodium via conventional liposomes, ethosomes, and transfersomes. BioMed Res Int 2013:1–7 Ghanbarzadeh S, Khorrami A, Arami S (2014) Preparation of optimized Naproxen nano liposomes using response surface methodology. J Pharm Investig 44:33–39 Godin B, Touitou E (2005) Erythromycin ethosomal systems: physicochemical characterization and enhanced antibacterial activity. Curr Drug Deliv 2:269–275 Green PG (1996) Iontophoretic delivery of peptide drugs. J Controlled Release 41:33–48 Green PG, Hinz RS, Cullander C, Yamane G, Guy RH (1991) Lontophoretic delivery of amino acids and amino acid derivatives across the skin in vitro. Pharm Res 8:1113–1120 Gujjar M, Banga AK (2014) Iontophoretic and Microneedle Mediated Transdermal Delivery of Glycopyrrolate. Pharmaceutics 6:663–671 Guo J, Ping Q, Zhang L (2000) Transdermal delivery of insulin in mice by using lecithin vesicles as a carrier. Drug Deliv 7:113–116 Gupta M, Goyal AK, Paliwal SR, Paliwal R, Mishra N, Vaidya B, Dube D, Jain SK, Vyas SP (2010) Development and characterization of effective topical liposomal system for localized treatment of cutaneous candidiasis. J Liposome Res 20:341–350 Guy RH, Kalia YN, Delgado-Charro MB, Merino V, López A, Marro D (2000) Iontophoresis: electrorepulsion and electroosmosis. J Controlled Release 64:129–132 Guy RH, Delgado-Charro MB, Kalia YN (2001) Iontophoretic transport across the skin. Skin Pharmacol Physiol 14:35–40 Hamada Y, Komatsu T, Seto Y, Matsubara H, Kume H, Sunakawa K, Yago K (2010) [Liposomal-amphotericin B efficacy and safety]. Kansenshogaku zasshi. J Jpn Assoc Infect Dis 84:193–198 Hiruta Y, Hattori Y, Kawano K, Obata Y, Maitani Y (2006) Novel ultra-deformable vesicles entrapped with bleomycin and enhanced to penetrate rat skin. J Controlled Release 113:146–154 Hisoire G, Bucks D (1997) An unexpected finding in percutaneous absorption observed between haired and hairless guinea pig skin. J Pharm Sci 86:398–400 Hoogstraate A, Srinivasan V, Sims S, Higuchi W (1994) Iontophoretic enhancement of peptides: behaviour of leuprolide versus model permeants. J Controlled Release 31:41–47 Horwitz E, Pisanty S, Czerninski R, Helser M, Eliav E, Touitou E (1999) A clinical evaluation of a novel liposomal carrier for acyclovir in the topical treatment of recurrent herpes labialis. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol 87:700–705 Hu C, Rhodes DG (1999) Proniosomes: a novel drug carrier preparation. Int J Pharm 185:23–35 Ismailova G, Efremenko V, Savel’eva I (2006) Efficacy of a new magnet-driven liposomal form of prednisolone in the treatment of experimental allergic dermatitis. Pharm Chem J 40:177–181 Jain N, Talegonkar S, Jain N (2004) New ways to enter the blood stream: emerging strategies in transdermal drug delivery. Pharm Rev 10:41–59 Jenkins S, Liversidge G, Liversidge E (2008) Nanoparticulate tacrolimus formulations. Google Patents Jeon S-O, Hwang H-J, Oh D-H, Seo J-E, Chun K-H, Hong S-M, Kim M-J, Kim W-C, Park M-S, Yoon C-H (2012) Enhanced percutaneous delivery of recombinant human epidermal growth factor employing nano-liposome system. J Microencapsul 29:234–241 Jose A, Mandapalli PK, Venuganti VVK (2015) Liposomal hydrogel formulation for transdermal delivery of pirfenidone. J Liposome Res 26:1–9 Juluri A, Murthy SN (2014) Transdermal iontophoretic delivery of a liquid lipophilic drug by complexation with an anionic cyclodextrin. J Controlled Release 189:11–18 Juluri A, Peddikotla P, Repka MA, Murthy SN (2013) Transdermal iontophoretic delivery of propofol: a general anaesthetic in the form of its phosphate salt. J Pharm Sci 102:500–507 Kajimoto K, Yamamoto M, Watanabe M, Kigasawa K, Kanamura K, Harashima H, Kogure K (2011) Noninvasive and persistent transfollicular drug delivery system using a combination of liposomes and iontophoresis. Int J Pharm 403:57–65 Kalia YN, Naik A, Garrison J, Guy RH (2004) Iontophoretic drug delivery. Adv Drug Deliv Rev 56:619–658 Kantaria S, Rees GD, Lawrence MJ (1999) Gelatin-stabilised microemulsion-based organogels: rheology and application in iontophoretic transdermal drug delivery. J Controlled Release 60:355–365 Kasha PC, Anderson CR, Morris RL, Sembrowich WL, Chaturvedula A, Banga AK (2012) Subcutaneous concentrations following topical iontophoretic delivery of diclofenac. Drug Discov Ther 6:256–262 Kasting GB, Keister J (1989) Application of electrodiffusion theory for a homogeneous membrane to iontophoretic transport through skin. J Controlled Release 8:195–210 Kato A, Ishibashi Y, Miyake Y (1987) Effect of egg yolk lecithin on transdermal delivery of bunazosin hydrochloride. J Pharm Pharmacol 39:399–400 Kigasawa K, Miyashita M, Kajimoto K, Kanamura K, Harashima H, Kogure K (2012) Efficient intradermal delivery of superoxide dismutase using a combination of liposomes and iontophoresis for protection against UV-induced skin damage. Biol Pharm Bull 35:781–785 Kim A, Green PG, Rao G, Guy RH (1993) Convective solvent flow across the skin during iontophoresis. Pharm Res 10:1315–1320 Kim ST, Jang D-J, Kim JH, Park JY, Lim JS, Lee SY, Lee K-M, Lim S-J, Kim C-K (2009) Topical administration of cyclosporin A in a solid lipid nanoparticle formulation. Pharmazie 64:510–514 Kirjavainen M, Urtti A, Jääskeläinen I, Marjukka Suhonen T, Paronen P, Valjakka-Koskela R, Kiesvaara J, Mönkkönen J (1996) Interaction of liposomes with human skin in vitro—the influence of lipid composition and structure. Biochim Biophys Acta 1304:179–189 Kirjavainen M, Urtti A, Valjakka-Koskela R, Kiesvaara J, Mönkkönen J (1999) Liposome skin interactions and their effects on the skin permeation of drugs. Eur J Pharm Sci 7:279–286 Knoblauch P, Moll F (1993) In vitro pulsatile and continuous transdermal delivery of buserelin by iontophoresis. J Controlled Release 26:203–212 Korbel J, Sebok B, Kerenyi M, Mahrle G (2001) Enhancement of the antiparakeratotic potency of calcitriol and tacalcitol in liposomal preparations in the mouse tail test. Skin Pharmacol Physiol 14:291–295 Kulkarni S, Banga A, Betageri G (1996) Delivery of liposome encapsulated colchicine across human cadaver skin using iontophoresis. Pharm Res 13:S361–S369 Kumar R, Philip A (2007) Modified transdermal technologies: breaking the barriers of drug permeation via the skin. Trop J Pharm Res 6:633–644 Kumar S, Char H, Patel S, Piemontese D, Iqbal K, Malick AW, Neugroschel E, Behl CR (1992a) Effect of iontophoresis on in vitro skin permeation of an analogue of growth hormone releasing factor in the hairless guinea pig model. J Pharm Sci 81:635–639 Kumar S, Char H, Patel S, Piemontese D, Malick AW, Iqbal K, Neugroschel E, Behl CR (1992b) In vivo transdermal iontophoretic delivery of growth hormone releasing factor GRF (1–44) in hairless guinea pigs. J Controlled Release 18:213–220 Lakshmi P, Devi GS, Bhaskaran S, Sacchidanand S (2007) Niosomal methotrexate gel in the treatment of localized psoriasis: phase I and phase II studies. Indian J Dermatol Venereol Leprol 73:157 Landmann L (1988) The epidermal permeability barrier. Anat Embryol 178:1–13 Lau DT-W, Sharkey JW, Petryk L, Mancuso FA, Yu Z, Francis L (1994) Effect of current magnitude and drug concentration on lontophoretic delivery of octreotide acetate (Sandostatin®) in the rabbit. Pharm Res 11:1742–1746 Lee S, Lee J, Choi YW (2007a) Characterization and evaluation of freeze-dried liposomes loaded with ascorbyl palmitate enabling anti-aging therapy of the skin. Bull Korean Chem Soc 28:99 Lee S, Lee J, Choi YW (2007b) Skin permeation enhancement of ascorbyl palmitate by liposomal hydrogel (lipogel) formulation and electrical assistance. Biol Pharm Bull 30:393–396 Lee S, Jeong J, Kim S, Lee K, Ahn B, Kang M, Choi Y (2012) Topical formulation of retinyl retinoate employing nanostructured lipid carriers. J Pharm Investig 42:243–250 Lelawongs P, Jue-Chen L, Siddiqui O, Chien YW (1989) Transdermal iontophoretic delivery of arginine-vasopressin (I): physicochemical considerations. Int J Pharm 56:13–22 Li J, Li X, Zhang Y, Zhou XK, Yang HS, Chen XC, Wang YS, Wei YQ, Chen LJ, Hu HZ (2010) Gene therapy for psoriasis in the K14-VEGF transgenic mouse model by topical transdermal delivery of interleukin-4 using ultradeformable cationic liposome. J Gene Med 12:481–490 Liu W, Hu M, Liu W, Xue C, Xu H, Yang X (2008) Investigation of the carbopol gel of solid lipid nanoparticles for the transdermal iontophoretic delivery of triamcinolone acetonide acetate. Int J Pharm 364:135–141 Magdassi S (1997) Delivery systems in cosmetics. Colloids Surf A 123:671–679 Maghraby GME, Williams AC, Barry BW (1999) Skin delivery of oestradiol from deformable and traditional liposomes: mechanistic studies. J Pharm Pharmacol 51:1123–1134 Malakar J, Sen SO, Nayak AK, Sen KK (2012) Formulation, optimization and evaluation of transferosomal gel for transdermal insulin delivery. Saudi Pharm J 20:355–363 Manosroi A, Khanrin P, Lohcharoenkal W, Werner RG, Götz F, Manosroi W, Manosroi J (2010) Transdermal absorption enhancement through rat skin of gallidermin loaded in niosomes. Int J Pharm 392:304–310 Marro D, Guy RH, Delgado-Charro MB (2001a) Characterization of the iontophoretic permselectivity properties of human and pig skin. J Controlled Release 70:213–217 Marro D, Kalia YN, Delgado-Charro MB, Guy RH (2001b) Contributions of electromigration and electroosmosis to iontophoretic drug delivery. Pharm Res 18:1701–1708 Martin M, Curley P, Devane J, Kelly J (1991) In vitro transdermal delivery of desmopressin. In: Scott RC, Guy RH, Hadgraft J, Bodde HE (eds) Prediction of percutaneous penetration. IBC Technical Services Ltd., London, pp 97–104 Maurer N, Fenske DB, Cullis PR (2001) Developments in liposomal drug delivery systems. Expert Opin Biol Ther 1:923–947 Mezei M, Gulasekharam V (1980) Liposomes—a selective drug delivery system for the topical route of administration I. Lotion dosage form. Life Sci 26:1473–1477 Miller LL, Kolaskie CJ, Smith GA, Rivier J (1990) Transdermal iontophoresis of gonadotropin releasing hormone (LHRH) and two analogues. J Pharm Sci 79:490–493 Minkowitz HS, Danesi H, Ding L, Jones JB (2015) Development of the fentanyl iontophoretic transdermal system (ITS) for patient-controlled analgesia of postoperative pain management. Pain Manag 5(5):327–337 Mishra V, Mahor S, Rawat A, Dubey P, Gupta PN, Singh P, Vyas SP (2006) Development of novel fusogenic vesosomes for transcutaneous immunization. Vaccine 24:5559–5570 Miyachi Y, Imamura S, Niwa Y (1987) Decreased skin superoxide dismutase activity by a single exposure of ultraviolet radiation is reduced by liposomal superoxide dismutase pretreatment. J Investig Dermatol 89:111–112 Morimoto K, Iwakura Y, Nakatani E, Miyazaki M, Tojima H (1992) Effects of proteolytic enzyme inhibitors as absorption enhancers on the transdermal iontophoretic delivery of calcitonin in rats. J Pharm Pharmacol 44:216–218 Mura P, Maestrelli F, González-Rodríguez ML, Michelacci I, Ghelardini C, Rabasco AM (2007) Development, characterization and in vivo evaluation of benzocaine-loaded liposomes. Eur J Pharm Biopharm 67:86–95 Nicoli S, Santi P, Couvreur P, Couarraze G, Colombo P, Fattal E (2001) Design of triptorelin loaded nanospheres for transdermal iontophoretic administration. Int J Pharm 214:31–35 Nishihata T, Kotera K, Nakano Y, Yamazaki M (1987) Rat percutaneous transport of diclofenac and influence of hydrogenated soya phospholipids. Chem Pharm Bull 35:3807–3812 Nounou MM, El-Khordagui LK, Khalafallah NA, Khalil SA (2008) Liposomal formulation for dermal and transdermal drug delivery: past, present and future. Recent Pat Drug Delivery Formulation 2:9–18 Oh S (2013) Effect of pH and penetration enhancers on electroosmotic flow and flux through skin. J Pharm Investig 43:37–44 Padmanabhan R, Phipps J, Lattin G, Sawchuk R (1990) In vitro and in vivo evaluation of transdermal iontophoretic delivery of hydromorphone. J Controlled Release 11:123–135 Paolino D, Lucania G, Mardente D, Alhaique F, Fresta M (2005) Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers. J Controlled Release 106:99–110 Paolino D, Cosco D, Muzzalupo R, Trapasso E, Picci N, Fresta M (2008) Innovative bola-surfactant niosomes as topical delivery systems of 5-fluorouracil for the treatment of skin cancer. Int J Pharm 353:233–242 Park J-B, Noh H-G, Jung J-H, Kim J-M, Kang C-Y (2012) Enhanced transdermal delivery and optimization of nano-liposome preparation using hydrophilic drug. J Pharm Investig 42:57–63 Patel RP, Patel H, Baria AH (2009) Formulation and evaluation of liposomes of ketoconazole. Int J Drug Deliv Technol 1:16–23 Patel N, Jain S, Madan P, Lin S (2014) Influence of electronic and formulation variables on transdermal iontophoresis of tacrine hydrochloride. Pharm Dev Technol 20(4):442–457 Patel H, Joshi A, Joshi A, Stagni G (2015) Effect of microporation on passive and iontophoretic delivery of diclofenac sodium. Drug Dev Ind Pharm 25:1–6 Phipps J, Padmanabhan R, Lattin G (1989) Iontophoretic delivery model inorganic and drug ions. J Pharm Sci 78:365–369 Pierre MBR (2011) Liposomal system as drug delivery vehicles for dermal and transdermal applications. Arch Dermatol Res 303:607–621 Pierre MB, Tedesco AC, Marchetti JM, Bentley MVL (2001) Stratum corneum lipids liposomes for the topical delivery of 5-aminolevulinic acid in photodynamic therapy of skin cancer: preparation and in vitro permeation study. BMC Dermatol 1:5 Potts RO, Francoeur ML (1990) Lipid biophysics of water loss through the skin. Proc Natl Acad Sci USA 87:3871–3873 Prausnitz MR, Langer R (2008) Transdermal drug delivery. Nat Biotechnol 26:1261–1268 Priya B, Rashmi T, Bozena M (2006) Transdermal iontophoresis. Expert Opin Drug Deliv 3(1):127–138 Prottey C, Hartop PJ, Press M (1975) Correction of the cutaneous manifestations of essential fatty acid deficiency in man by application of sunflower-seed oil to the skin. J Investig Dermatol 64:228–234 Prüfer K, Jirikowski GF (1996) Liposomal incorporation changes the effect of 1.25-dihydroxyvitamin D 3 on the phospholipase C signal transduction pathway and the eicosanoid cascade on keratinocytes in vitro. Biochem Pharmacol 51:247–252 Rai R, Srinivas C (2005) Iontophoresis in dermatology. Indian J Dermatol Venereol Leprol 71:236 Rieger M (1987) Skin lipids and their importance to cosmetic science. Cosmet Toilet 102:45–49 Sage BH, Riviere JE (1992) Model systems in iontophoresis—transport efficacy. Adv Drug Deliv Rev 9:265–287 Salunkhe S, Bhatia N, Thorat J, Choudhari P, Bhatia M (2014) Formulation, development and evaluation of ibuprofen loaded nanoemulsion prepared by nanoprecipitation technique: use of factorial design approach as a tool of optimization methodology. J Pharm Investig 44:273–290 Schmid M-H, Korting H (1996) Therapeutic progress with topical liposome drugs for skin disease. Adv Drug Deliv Rev 18:335–342 Schramlova J, Blazek K, Bartackova M, Otova B, Mardesicova L, Zizkovský V, Hulinska D (1996) Electron microscopic demonstration of the penetration of liposomes through skin. Folia Biol 43:165–169 Sessa G, Weissmann G (1970) Incorporation of lysozyme into liposomes a model for structure-linked latency. J Biol Chem 245:3295–3301 Seth AK, Misra A, Umrigar D (2005) Topical liposomal gel of idoxuridine for the treatment of herpes simplex: pharmaceutical and clinical implications. Pharm Dev Technol 9:277–289 Shahiwala A, Misra A (2002) Studies in topical application of niosomally entrapped nimesulide. J Pharm Pharm Sci 5:220–225 Shaji J, Varkey D (2013) Silica-coated solid lipid nanoparticles enhance antioxidant and antiradical effects of meloxicam. J Pharm Investig 43:405–416 Shumilov M, Touitou E (2010) Buspirone transdermal administration for menopausal syndromes, in vitro and in animal model studies. Int J Pharm 387:26–33 Siddiqui O, Roberts MS, Polack AE (1985) The effect of iontophoresis and vehicle pH on the in vitro permeation of lignocaine through human stratum corneum. J Pharm Pharmacol 37:732–735 Singh P, Maibach HI (1993) Iontophoresis in drug delivery: basic principles and applications. Crit Rev Ther Drug Carrier Syst 11:161–213 Singh J, Roberts M (1989) Transdermal delivery of drugs by iontophoresis: a review. Drug Des Deliv 4:1–12 Singh P, Boniello S, Liu P, Dinh S (1999) Transdermal iontophoretic delivery of methylphenidate HCl in vitro. Int J Pharm 178:121–128 Singh B, Mehta G, Kumar R, Bhatia A, Ahuja N, Katare O (2005) Design, development and optimization of nimesulide-loaded liposomal systems for topical application. Curr Drug Deliv 2:143–153 Sloan JB, Soltani K (1986) Iontophoresis in dermatology: a review. J Am Acad Dermatol 15:671–684 Smith EW, Maibach HI (1995) Percutaneous penetration enhancers. CRC Press, New York, pp 395–399 Srinivasan V, Su MH, Higuchi WI, Behl C (1990) Iontophoresis of polypeptides: effect of ethanol pretreatment of human skin. J Pharm Sci 79:588–591 Thysman S, Hanchard C, Preat V (1994) Human calcitonin delivery in rats by iontophoresis. J Pharm Pharmacol 46:725–730 Tomoda K, Terashima H, Suzuki K, Inagi T, Terada H, Makino K (2011) Enhanced transdermal delivery of indomethacin-loaded PLGA nanoparticles by iontophoresis. Colloids Surf B 88:706–710 Tomoda K, Terashima H, Suzuki K, Inagi T, Terada H, Makino K (2012a) Enhanced transdermal delivery of indomethacin using combination of PLGA nanoparticles and iontophoresis in vivo. Colloids Surf B 92:50–54 Tomoda K, Watanabe A, Suzuki K, Inagi T, Terada H, Makino K (2012b) Enhanced transdermal permeability of estradiol using combination of PLGA nanoparticles system and iontophoresis. Colloids Surf B 97:84–89 Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M (2000) Ethosomes—novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Controlled Release 65:403–418 Trotta M, Peira E, Carlotti ME, Gallarate M (2004) Deformable liposomes for dermal administration of methotrexate. Int J Pharm 270:119–125 Van Hal D, Van Rensen A, De Vringer T, Junginger H, Bouwstra J (1996a) Diffusion of estradiol from non-ionic surfactant vesicles through human stratum corneum in vitro. STP Pharm Sci 6:72–78 van Hal DA, Jeremiasse E, de Vringer T, Junginger HE, Bouwstra JA (1996b) Encapsulation of lidocaine base and hydrochloride into non-ionic surfactant vesicles (NSVs) and diffusion through human stratum corneum in vitro. Eur J Pharm Sci 4:147–157 Vora B, Khopade AJ, Jain N (1998) Proniosome based transdermal delivery of levonorgestrel for effective contraception. J Controlled Release 54:149–165 Vutla NB, Betageri GV, Banga AK (1996) Transdermal iontophoretic delivery of enkephalin formulated in liposomes. J Pharm Sci 85:5–8 Wang Y, Thakur R, Fan Q, Michniak B (2005) Transdermal iontophoresis: combination strategies to improve transdermal iontophoretic drug delivery. Eur J Pharm Biopharm 60:179–191 Weiner N (1998) Targeted follicular delivery of macromolecules via liposomes. Int J Pharm 162:29–38 Wertz PW, Abraham W, Landmann L, Downing DT (1986) Preparation of liposomes from stratum corneum lipids. J Investig Dermatol 87:582–584 Xin C, Lihong W, Fei H, Yan W, Qifang W, Yang Y, Yue Y, San-ming L (2014) To enhance the efficiency of nefopam transdermal iontophoresis by using a novel method based on ion-exchange fiber. Drug Dev Ind Pharm 40:9–16 Yamamoto R, Takasuga S, Kominami K, Sutoh C, Kinoshita M, Kanamura K, Takayama K (2013) Iontophoretic Transdermal Delivery of Glycyrrhizin: effects of pH, Drug Concentration, Co-ions, Current Intensity, and Chemical Enhancers. Chem Pharm Bull 61:1275–1281 Yoon G, Park JW, Yoon I-S (2013) Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs): recent advances in drug delivery. J Pharm Investig 43:353–362 Yu H-Y, Liao H-M (1996) Triamcinolone permeation from different liposome formulations through rat skin in vitro. Int J Pharm 127:1–7